Cargando…
Toll-Like Receptors as Novel Therapeutic Targets for Ovarian Cancer
Ovarian cancer (OC) is an aggressive disease that affects approximately 1 in 70 women and has a poor prognosis (<50%, 5-year survival rate), in part because it is often diagnosed at a late stage. There are three main types of OC: neoplasms of surface epithelial, germ cell, or stromal origin, with...
Autores principales: | Muccioli, Maria, Sprague, Leslee, Nandigam, Harika, Pate, Michelle, Benencia, Fabian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317035/ https://www.ncbi.nlm.nih.gov/pubmed/22530148 http://dx.doi.org/10.5402/2012/642141 |
Ejemplares similares
-
Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies
por: Muccioli, Maria, et al.
Publicado: (2014) -
Modulation of double-stranded RNA pattern recognition receptor signaling in ovarian cancer cells promotes inflammatory queues
por: Muccioli, Maria, et al.
Publicado: (2018) -
Dendritic Cells The Tumor Microenvironment and the Challenges for an Effective Antitumor Vaccination
por: Benencia, Fabian, et al.
Publicado: (2012) -
The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells
por: Sprague, Leslee, et al.
Publicado: (2011) -
Generation and Labeling of Murine Bone Marrow-derived Dendritic Cells with Qdot Nanocrystals for Tracking Studies
por: Muccioli, Maria, et al.
Publicado: (2011)